Effects of cyclosporin, FK506, and rapamycin on graft-vessel disease
Open Access
- 23 November 1991
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 338 (8778) , 1297-1298
- https://doi.org/10.1016/0140-6736(91)92594-r
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- THE IMPORTANCE OF THE SPLEEN FOR THE IMMUNOSUPPRESSIVE ACTION OF CYCLOSPORINE IN TRANSPLANTATIONTransplantation, 1991
- EFFECTS OF COMBINATION TREATMENT WITH FK506 AND CYCLOSPORINE ON SURVIVAL TIME AND VASCULAR CHANGES IN RENAL-ALLOGRAFT-RECIPIENT DOGSTransplantation, 1989
- The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes.The Journal of Immunology, 1989
- RAPAMYCIN FOR IMMUNOSUPPRESSION IN ORGAN ALLOGRAFTINGThe Lancet, 1989
- Cyclosporin A inhibits smooth muscle proliferation in the vascular response to injury.Proceedings of the National Academy of Sciences, 1988